Violence Fatality Review Committee Dr. Erica Richards Confirmation Resolution of 2025

MURIEL BOWSER
MAYOR
January 8, 2025
The Honorable Phil Mendelson
Chairman
Council of the District of Columbia
John A. Wilson Building
1350Pennsylvania Avenue,N W, Suite 504
Washington, DC 20004
Dear Chairman Mendelson:
In accordance with section 2 of the Confirmation Act of 1978, effective March 3, 1979 (D.C. Law 2-
142; D.C. Official Code § 1-523.01 ), and pursuant to section 3043 of the Fatality Review Committee
Amendment Act of 2018, effective October 30, 2018 (D.C. Law 22-168; D.C. Official Code § 5-
1431.02), I am pleased to nominate the following individual:
Dr. Erica Richards
Iris Street, NW
Washington, DC 20012
(Ward 4)
for reappointment as a representative from a hospital located in the District of Columbia member of
the Violence Fatality Review Committee, for a term to end October 12, 2027.
Enclosed, you will find biographical information detailing the experience of the above-mentioned
nominee, together with a proposed resolution to assist the Council during the confirmation process.
I would appreciate the Council's earliest consideration of this nomination for confirmation. Please
do not hesitate to contact me, or Steven Walker, Director, Mayor's Office of Talent and
Appointments, should the Council require additional information.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
A PROPOSED RESOLUTION
~~
Chairman Phil Mendelson
at the request of the Mayor
IN THE COUNCIL OF THE DISTRICT OF COLUMBIA
To confirm the reappointment of Dr. Erica Richards to the Violence Fatality Review Committee.
RESOLVED, BY THE COUNCIL OF THE DISTRICT OF COLUMBIA, That this
resolution may be cited as the "Violence Fatality Review Committee Dr. Erica Richards
Confirmation Resolution of 2025".
Sec. 2. The Council of the District of Columbia confirms the reappointment of:
Dr. Erica Richards
Iris Street, NW
Washington, DC 20012
(Ward 4)
as a representative of a hospital located in the District of Columbia member of the Violence
Fatality Review Committee, established by section 3042 of the Fatality Review Committee
Amendment Act of 2018, effective October 30, 2018 (D.C. Law 22-168; D.C. Official Code§ 5-
1431.01), for a term to end October 12, 2027.
Sec. 3. The Council of the District of Columbia shall transmit a copy of this resolution,
upon its adoption, to the nominee and to the Office of the Mayor.
Sec. 4. This resolution shall take effect immediately.
Erica Martin Richards, MD, PhD
CURRICULUMVITAE
DEMOGRAPHICAND PERSONALINFORMATION
ContactInformatio!

CurrentAppointments
October2017-Present ChairandMedicalDirector
DepartmentofPsychiatryandBehavioralHealth
SibleyMemorialHospital
5255LoughboroRoad,NW
Washington,DC 20016
October2017-Present AssistantProfessor
PersonalData
DepartmentofPsychiatryandBehavioralSciences
The JohnsHopkinsSchoolofMedicine
733N BroadwayStreet
Baltimore,MD 21205
EducationandTraining
Undergraduate:
GraduateEducation:
MedicalEducation:
SpelmanCollege,Atlanta,GA.BS.
350SpelmanLane
Atlanta,GA 30314
August1995-May1999
BS.Biology,CumLaude.
UniversityofMarylandSchoolofMedicine
655W.BaltimoreStreet
Baltimore,MD 21201
July2001-May2006
DoctorofPhilosophyinNeuroscience
PrimaryMentor:GaryFiskum,PhD
UniversityofMarylandSchoolofMedicine
655W.BaltimoreStreet
EricaM.Richards,MD,PhD CurriculumVitae Page2of11
Internship:
Residency:
Fellowship:
Baltimore,MD 21201
‘August1999-May2008(CombinedMD/PhDProgram)
DoctorofMedicine
CombinedPsychiatry-InternalMedicineInternship
JohnsHopkinsBayviewMedicalCenter5300AlphaCommonsDrive
Baltimore,MD. 21224
July2008-June2009ConstantineLyketsos,MD-DepartmentChair
TheJohnsHopkinsHospital
DepartmentofPsychiatryandBehavioralSciences
AdultPsychiatryResidencyProgram
600N.WolfeStreet
Baltimore,MD 21287
July2009-June2012(AdministrativeResident2010-2011)
J.RaymondDePaulo,Jr.,MD ~DepartmentChair
TheNationalInstitutesofHealth
ClinicalResearchFellowshipattheNationalInstituteofMentalHealth
10CenterDrive
CRC-Building10,room6-5340
Bethesda,Maryland20892-1276
September2012-September2015
JoyceChung,MD —FellowshipDirector
PriorProfessionalExperience:
2015-2017
2016-2017
2011-2012
AttendingPhysician
PsychiatricConsultationService
OfficeoftheClinicalDirector
NationalInstituteofMentalHealth
10CenterDrive
CRC-Building10,room6-5340
Bethesda,Maryland20892-1276
AssistantProfessorofPsychiatry
GeorgetownUniversityMedicalCenter
3900 Reservoir Road, NW
Med-DentBuilding,RoomNW 208
Washington,DC20057
July2016-present
Chief Resident
DepartmentofPsychiatryandBehavioralSciences‘AdultPsychiatryResidencyProgram
EricaM.Richards,MD,PhD CurriculumVitae Page3of11
TheJohnsHopkinsHospital
2012-2017 PrivatePracticePhysician
EricaRichards,MD,PhD,LLC
5480WisconsinAvenue
ChevyChase,MD
PUBLICATIONS
i.OriginalResearch
10.
‘WyseR,Hwang,W,Ahmed,A,RichardsE,DevilleC.DiversitybyRace,Ethnicity,andSexwithintheUS
PsychiatryPhysicianWorkforce.2020July23.Doi10.1007.PMID32705570.
BallardED,YarringtonJS,FarmerCA,RichardsE,Machado-VieiraR,KadriuB,NiciuMJ,YuanP,ParkL,
ZarateCAJr.CharacterizingtheCourseofSuicidalIdeationResponsetoKetamine.JAffectiveDisorders.
2018Dec1:241:86-93.Doi10.1016.Epub2018Jul30.PMID30099268.
RichardsEM,Zanotti-FregonaraP,FujitaM,NewmanL,FarmerC,BallardED,Machado-VieiraR,YuanP,
NiciuMJ,LyooCH,HenterID,SalvadoreG,DrevetsWC,KolbH,InnisRB,ZarateCAJr.PETRadioligand
BindingtoTranslocatorProtein(TSPO)isincreasedinUnmedicationDepressedSubjects.EINMMI
Research.2018Jul3:8(1):57.doi:10.1186/s13550-018-0401-9,PMID29971587
VandeVoortJt,BallardED,LuckenbaughDA,BernertRA,RichardsEM,NiciuMi,ParkLT,Machado-
VieiraR,DuncanWC Jr,ZarateCAJr.AntisuicidalResponseFolloingKetamineInfusionisAssociatedwith
DecreasedNighttimeWakefulnessinMajorDepressiveDisorderandBipolarDisorder.JClinPsychiatry.
2017Sep/Oct;78(8):1068-1074,doi:10.4088
BallardED,WillsK,LallyN,RichardsEM,LuckenbaughDA,WallsT,AmeliR,NiciuMJ,BrutscheNE,Park
ZarateCAJr.AnhedoniaasaClinicalCorrelateofSuicidalThoughtsinClinicalKetamineTrials.JAffect
Disord.2017Aug15;218:195-200.doi:10.1016/j.jad.017.04.057.PMID:28477497.
FujitaM,RichardsEM,NiciuMJ,lonescuDF,ZoghbiSS,HongJ,TeluS,HinesCS,PikeVW,ZarateCA,
InnisRB.cAMPSignalinginBrainisDecreasedinUnmedicatedDepressedPatientsandIncreasedby
TreatmentwithaSelectiveSerotoninReuptakeInhibitor.MolPsychiatry.2017May;22(5):754-759.doi:
10.1038/mp.2016.171.PMID:27725657.
BallardED,VandeVoortJL,BernertRA,LuckenbaughDA,RichardsEM, NiciuMJ,FureyML,DuncanWC
JR,ZarateCAJr.NocturnalWakefulnessisAssociatedwithNext-DaySuicidalIdeationinMajor
DepressiveDisorderandBipolarDisorder.JClinPsychiatry.2016Jun;77(6):825-31.Doi:10.4088/JCP.
PMID27337418.
Machado-VieiraR,GoldPW,LuckenbaughDA,BallardED,RichardsEM,HenterID,DeSousaRT,Niciu
M4,YuanP,ZarateCA Jr.TheRoleofAdipokinesintheRapidAntidepressantEffectsofKetamine.Mol
Psychiatry.2016Apr5.doi:10.1038/mp.2016.36.[Epubaheadofprint]PMID:27046644.Role:bench
scientificexperimentsinvolvinganalysisofplasmaandsubsequentdataanalysis;patientscreensand
ongoingevaluation,writingofMethodsandResultssections.
JasoBA,NiciuMJ,ladarolaND,LallyN,RichardsEM,ParkM,BallardED,NugentAC,Machado-VieiraR,
ZarateCA Jr.TherapeuticModulationofGlutamateReceptorsinMajorDepressiveDisorder.Curr
Neuropharmacol.2016Mar21.[Epubaheadofprint].PMID:26997505.Role:Clinicaltrial-mentorship
ofprimaryauthor,dataanalysis;patientscreensandongoingevaluation,writingofMethodsand
Resultssections.
RichardsEM,MathewsDC,LuckenbaughDA,lonescuDF,Machado-VieiraR,NiciuMJ,DuncanWC,
NolanNM,Franco-ChavesJA,HudzikT,MaciagC,LiS,CrossA,SmithMA,ZarateCAJr.Arandomized,
placebo-controlledpilottrialofthedeltaopioidreceptoragonistAZD2327inanxiousdepression.

EricaM.Richards,MD,PhD CurriculumVitae Page4of11
1.
12.
13.
14,
15.
16.
17.
18.
19.
20.
Psychopharmacology(Berl).2016Mar;233(6):1119-30.doi:10.1007/s00213-015-4195-4,Epub2016Jan
4,PMID:26728893.
LallyN,AnL,BanerjeeD,NiciuMJ,LuckenbaughDA,RichardsEM,RoiserJP,ShenJ,ZarateCAJr,
NugentAC.Reliabilityof7T(1)H-MRSmeasuredhumanprefrontalcortexglutamate,glutamine,and
glutathionesignalsusinganadaptedechotimeoptimizedPRESSsequence:A between-andwithin-
sessionsinvestigation.JMagnResonImaging.2016Jan;43(1):88-98.doi:10.1002/jmri.24970.Epub2015
Jun7.PubMedPMID:26059603;PubMedCentralPMCID:PMC4671833.
BallardED,LuckenbaughDA,RichardsEM,WallsTL,BrutschéNE,AmeliR,NiciuMJ,VandeVoortJL,
ZarateCA Jr.Assessingmeasuresofsuicidalideationinclinicaltrialswitharapid-actingantidepressant.J
PsychiatrRes.2015Sep;68:68-73.doi:10.1016/j,jpsychires.2015.06.003.Epub2015Jun16.PubMed
PMID:26228403;PubMedCentralPMCID:PMC4522045.
lonescuDF,LuckenbaughDA,NiciuMJ,RichardsEM,ZarateCAJr.Asingleinfusionofketamine
improvesdepressionscoresinpatientswithanxiousbipolardepression.BipolarDisord.2015
Jun;17(4):438-43.doi:10.1111/bdi.12277.Epub2014Nov14.PubMedPMID:25400146;PubMed
CentralPMCID:PMC4431955.
lonescuDF,NugentAC,LuckenbaughDA,NiciuMJ,RichardsEM,ZarateCA,FureyML.Baselineworking
memoryactivationdeficitsindimensionalanxiousdepressionasdetectedbymagnetoencephalography.
ActaNeuropsychiatr.2015Jun;27(3):143-52.doi:10.1017/neu.2014.46.Epub2015Jan20.PubMed
PMID:25600154,
ladarolaND,NiciuMJ,RichardsEM,VandeVoortJL,BallardED,LundinNB,NugentAC,Machado-
R,ZarateCAJr.KetamineandotherN-methyl-D-aspartatereceptorantagonistsinthetreatmentof
depression:aperspectivereview.TherAdvChronicDis.2015May;6(3):97-114.doi:
10.1177/2040622315579059.Review.PMID:25954495.
XuAJ,NiciuMJ,LundinNB,LuckenbaughDA,lonescuDF,RichardsEM,VandeVoortJL,BallardED,
BrutscheNE,Machado-VieiraR,ZarateCAJr.LithiumandValproateLevelsDoNotCorrelatewith
Ketamine’sAntidepressantEfficacyinTreatment-ResistantBipolarDepression.NeuralPlast.
2015;2015:858251.doi:10.1155/2015/858251.Epub2015Jun7.PubMedPMID:26137324;PubMed
CentralPMCID:PMC4475570.
NiciuMJ,LuckenbaughDA,lonescuDF,RichardsEM,VandeVoortJL,BallardED,BrutscheNE,FureyML,
ZarateCAJr.Riluzolelikelylacksantidepressantefficacyinketaminenon-responders.JPsychiatrRes.
2014Nov;58:197-9.doi:10.1016/j.jpsychires.2014.07.022.Epub2014Aug6.PubMedPMID:25139008;
PubMedCentralPMCID:PMC4300112.
BallardED,lonescuDF,VandeVoortJL,NiciuMJ,RichardsEM,LuckenbaughDA,BrutschéNE,AmeliR,
FureyML,ZarateCAJr.Improvementinsuicidalideationafterketamineinfusion:relationshipto
reductionsindepressionandanxiety.J PsychiatrRes.2014Nov;58:161-6.doi:
10.1016/j.jpsychires.2014.07.027.Epub2014Aug12.PubMedPMID:25169854;PubMedCentral
PMCID:PMC4163501.
‘NiciuMJ,LuckenbaughDA,lonescuDF,RichardsEM,VandeVoortJL,BallardED,BrutscheNE,FureyML,
ZarateCAJr.Ketamine'santidepressantefficacyisextendedforatleastfourweeksinsubjectswitha
familyhistoryofanalcoholusedisorder.IntJNeuropsychopharmacol.2014Oct31;18(1).pii:pyu039.
doi:10.1093/ijnp/pyu039.PubMedPMID:25539512;PubMedCentralPMCID:PMC4303351.
‘SvenningssonP,BergL,MatthewsD,lonescuDF,RichardsEM,NiciuMJ,MalingerA,ToupsM,ManjiH,
TrivediMH,ZarateCAJr,GreengardP.Preliminaryevidencethatearlyreductioninp11levelsinnatural
killercellsandmonocytespredictsthelikelihoodofantidepressantresponsetochroniccitalopram.Mol

EricaM.Richards,MD,PhD CurriculumVitae Page5of11
21.
22.
23.
24,
25.
26.
27.
28.
29.
30.

Psychiatry.2014Sep;19(9):962-4.doi:10.1038/mp.2014.13.Epub2014Mar11.PubMedPMID:
24614495;PubMedCentralPMCID:PMC4161667.
lonescuDF,LuckenbaughDA,NiciuMJ,RichardsEM,SlonenaEE,VandeVoortJL,BrutscheNE,Zarate
CA4Jr.Effectofbaselineanxiousdepressiononinitialandsustainedantidepressantresponseto
ketamine.JClinPsychiatry.2014Sep;75(9):e932-8.doi:10.4088/JCP.14m09049.PubMedPMID:
25295436.
LundinNB,NiciuMJ,LuckenbaughDA,lonescuDF,RichardsEM,VandeVoortJL,BrutscheNE,Machado-
VieiraR,ZarateCAJr.BaselinevitaminB12andfolatelevelsdonotpredictimprovementindepression
afterasingleinfusionofketamine.Pharmacopsychiatry.2014Jul;47(4-5):141-4,doi:10.1055/s-0034-
1377042.Epub2014Jun23.PubMedPMID:24955551;PubMedCentralPMCID:PMC4174587.
NiciuMJ,LuckenbaughDA,lonescuDF,GuevaraS,Machado-VieiraR,RichardsEM,BrutscheNE,Nolan
NM,ZarateCAJr.Clinicalpredictorsofketamineresponseintreatment-resistantmajordepression.J
Psychiatry.2014May;75(5):e417-23.doi:10.4088/JCP.13m08698.PubMedPMID:24922494;
PubMed Central PMCID: PMC4310499.
LuckenbaughDA,NiciuMi,IonescuDF,NolanNM,RichardsEM,BrutscheNE,GuevaraS,ZarateCA.Do
thedissociativesideeffectsofketaminemediateitsantidepressanteffects?JAffectDisord.2014
Apr;159:56-61.doi:10.1016/j,jad.2014.02.017.Epub2014Feb18.PubMedPMID:24679390;PubMed
Central PMCID: PMC4065787.
NiciuMJ,LuckenbaughDA,lonescuDF,MathewsDC,RichardsEM,ZarateCAJr.Subanestheticdose
ketaminedoesnotinduceanaffectiveswitchinthreeindependentsamplesoftreatment-resistant
majordepression.BiolPsychiatry.2013Nov15;74(10):e23-4.doi:10.1016/j.biopsych.2013.01.038.Epub
2013 May 28. PubMed PMID: 23726512; PubMed Central PMCID: PMC3805682.
RiceP,MartinE,HeJR,FrankM,DeTollaL,HesterL,O'NeillT,MankaC,Benjamin|,NagarsekarA,Singh
1,HasdayJD.Febrile-rangehyperthermiaaugmentsneutrophilaccumulationandenhanceslunginjuryin
experimental gram-negative bacterialpneumonia. J Immunol. 2005 Mar 15;174(6):3676-85. PubMed
PMID: 15749906.
RichardsEM,RosenthalRE,KristianT,FiskumG.Postischemichyperoxiareduceshippocampalpyruvate
dehydrogenaseactivity.FreeRadicBiolMed,2006Jun1;40(11):1960-70.Epub2006Feb17.PubMed
PMID:16716897;PubMedCentralPMCID:PMC2570699.
RichardsEM,FiskumG,RosenthalRE,HopkinsI,McKennaMC.Hyperoxicreperfusionafterglobal
ischemiadecreaseshippocampalenergymetabolism.Stroke.2007May;38(5):1578-84.Epub2007Apr5.
PubMedPMID:17413048;PubMedCentralPMCID:PMC2601708.
MathewsDC,RichardsEM,NiciuMJ,lonescuDF,RasimasJJ,ZarateCAJr.NEUROBIOLOGICALASPECTS
OFSUICIDEANDSUICIDEATTEMPTSINBIPOLARDISORDER.Trans!Neurosci.2013Jun;4(2).doi:
10.2478/s13380-013-0120-7. PubMed PMID: 24294519; PubMed Central PMCID: PMC3840723.
ZengMC,NiciuMJ,LuckenbaughDA,lonescuDF,MathewsDC,RichardsEM,Franco-ChavesJ,Brutsche
NE,ZarateCAJr.Acutestresssymptomsdonotworseninposttraumaticstressdisorderandabusewith
a singlesubanesthetic dose of ketamine. BiolPsychiatry.2013 Jun 15;73(12):e37-8.doi:
10.1016/j.biopsych.2012.10.017.Epub 2012 Dec 13. PubMed PMID: 23245747.

ili.Reviews or EditorialsinRefereedJournals
1 lonescuDF,NiciuMJ,RichardsEM,ZarateCAJr.Pharmacologictreatmentofdimensionalanxious
depression:areview.PrimCareCompanionCNSDisord.2014;16(3).pii:PCC.13r01621.doi:
EricaM.Richards,MD,PhD CurriculumVitae Page6of11
10.4088/PCC.13r01621. Epub 2014 May 29. PubMed PMID: 25317369; PubMed Central PMCID:
PMC4195641.
2.NiciuMJ,MathewsDC,NugentAC,lonescuDF,FureyML,RichardsEM,Machado-VieiraR,ZarateCAJr.
Developingbiomarkersinmooddisordersresearchthroughtheuseofrapid-actingantidepressants.
Depress Anxiety.2014 Apr;31(4):297-307. doi:10.1002/da.22224. Epub 2013 Dec 18. Review. PubMed
PMID: 24353110; PubMed Central PMCID: PMC3984598.
3. Machado-VieiraR,Soeiro-De-SouzaMG,RichardsEM,TeixeiraAL,ZarateCAJr.Multiplelevelsof
impairedneuralplasticityandcellularresilienceinbipolardisorder:developingtreatmentsusingan
integratedtranslationalapproach.WorldJBiolPsychiatry.2014Feb;15(2):84-95.doi:
10.3109/15622975.2013.830775.Epub2013Sep2.Review.PubMedPMID:23998912;PubMedCentral
PMCID: PMC4180367.
4. Niciu MJ, Mathews DC, lonescu DF, Richards EM, Furey ML, Yuan P, Nugent AC, Henter ID,Machado-
VieiraR,ZarateCAJr.Biomarkersinmooddisordersresearch:developingnewandimproved
therapeutics.RevPsiquiatrClin.2014;41(5):131-134,PubMedPMID:26082563;PubMedCentralPMCID:
PMC4465361.
5. NiciuMJ,lonescuDF,RichardsEM,ZarateCAJr.Glutamateanditsreceptorsinthepathophysiologyand
treatmentofmajordepressivedisorder.JNeuralTransm(Vienna).2014Aug;121(8):907-24.doi:
10.1007/s00702-013-1130-x.Epub2013Dec8.Review.PubMedPMID:24318540;PubMedCentral
PMCID: PMC4048804.
6.RichardsEM,PayneJL.Themanagementofmooddisordersinpregnancy:alternativesto
antidepressants.CNS Spectr.2013 Oct;18(5):261-71.doi:10.1017/S1092852913000151. Epub 2013 Apr
10.Review.PubMedPMID:23570692.
7. Niciu MJ, lonescu DF, Mathews DC, Richards EM, ZarateCA Jr. Second messenger/signal transduction
pathwaysinmajormooddisorders:movingfrommembranetomechanismofaction,part|:major
depressivedisorder.CNSSpectr.2013Oct;18(5):231-41.doi:10.1017/S1092852913000059.Epub2013
Mar 5. Review. PubMed PMID: 23462230.
‘MJ,IonescuDF,MathewsDC,RichardsEM,ZarateCAJr.Secondmessenger/signaltransduction
pathwaysinmajormooddisorders:movingfrommembranetomechanismofaction,partIl:bipolar
disorder.CNSSpectr.2013Oct;18(5):242-51.doi:10.1017/S1092852913000138.Epub2013Mar11.
Review. PubMed PMID: 23472710; PubMed Central PMCID: PMC3936782.
9.lonescuDF,NiciuMJ,MathewsDC,RichardsEM,ZarateCA Jr.Neurobiologyofanxiousdepression:a
review.DepressAnxiety.2013Apr;30(4):374-85.doi:10.1002/da.22095.Epub2013Mar11.Review.
PubMedPMID:23495126;PubMedCentralPMCID:PMC3698573.
10.FiskumG,DanilovCA,MehrabianZ,BambrickLL,KristianT,McKennaMC,Hopkins|,RichardsEM,
RosenthalRE.Postischemicoxidativestresspromotesmitochondrialmetabolicfailureinneuronsand
astrocytes.Ann N Y Acad Sci.2008 Dec;1147:129-38. doi:10.1196/annals.1427.026. Review. PubMed
PMID:19076438;PubMedCentralPMCID:PMC3040634.
MartinE,RosenthalRE,FiskumG.Pyruvatedehydrogenasecomplex:metaboliclinktoischemicbrain
juryandtargetofoxidativestress.JNeurosciRes.2005Jan1-15;79(1-2):240-7.Review.PubMed
PMID: 15562436; PubMed CentralPMCID: PMC2570320.
12.FiskumG,RosenthalRE,VereczkiV,MartinE,HoffmanGE,ChinopoulosC,KowaltowskiA.Protection
againstischemicbraininjurybyinhibitionofmitochondrialoxidativestress.JBioenergBiomembr.2004
Aug;36(4):347-52. Review. PubMed PMID: 15377870.

EricaM.Richards,MD,PhD CurriculumVitae Page7of11
ili.ChaptersinBooksandElectronicChapters
1. ElizabethD.Ballard,EricaM.Richards,DawnF.lonescu,MarkJ.Niciu,JenniferVandeVoortandCarlos
A.ZarateJr.Experimentalpharmacologicapproachesforthereductionofsuicidalideationandbehavior.
InK.E.CannonandT.J.Hudzik(Eds.)Suicide:PhenomenologyandNeurobiology,Switzerland:Springer
InternationalPublishing,2014.
2. EricaM.RichardsandMarylandPao.SleepDisruptions.TheJohnsHopkinsPhippsPsychiatryGuide.
JohnsHopkinsPOC-ITCenter(JohnsHopkinsPointofCareInformationTechnologyCenter),Baltimore,
MD.October,2014.

FUNDING
1) Agency:NationalinstitutesofHealthRuthL.KirschsteinNRSAMD/PhD
IdentifyingNumber:F30PredoctoralFellowshipAward
TitleofProject:“ThePyruvateDehydrogenaseComplexasaTargetforOxidativeStressFollowing
Ischemia/Reperfusion”.
DatesofProjectPeriod:February2004-May2006.
CorrespondingPI:EricaMartin(Richards)
TotalDollarAmount:$42,675
RoleonProject:PI
Description:Thispredoctoralfellowshipawardprovidedadditionaltrainingandresearchsupportduring
mydissertationstudyontheeffectsofheartattackandstrokeonthebrain.
PercentEffort:100%

2) Agency:AmericanHeartAssociation
IdentifyingNumber:PredoctoralFellowshipAward
TitleofProject:“TheRoleofHypoxiainHippocampalMitochondriaFunctionFollowingCardiacArrest
andResuscitation”
DatesofProjectPeriod:October2001-June2003
CorrespondingPl:EricaMartin(Richards)
TotalDollarAmount:$23,500
RoleonProject:PI
Description:Thispredoctoralfellowshipawardprovidedadditionaltrainingandresearchsupport
duringmydissertationstudyontheeffectsofheartattackandstrokeonthebrain;
specificallyonmitochondrialfunctionfollowingischemia.
PercentEffort:100%

CLINICALACTIVITIES
Licensure: State: Maryland
license#: 00073634
InitialDate: 2/07/12

State: DistrictofColumbia
License# MD045656
InitialDate: 8/12/17
EricaM.Richards,MD,PhD CurriculumVitae Page8of11
Certification: ‘AmericanBoardofPsychiatryandNeurology
DateofCertification:9/15/14
DateofRecertification:September2024

DevelopmentofNational/internationallyRecognizedClinicalStandardofCare:
January2008 ‘AmericanHeartAssociation(AHA)Guidelinesincluderecommendationsforemergency
medicaltechnicianstotitrateinhaledoxygento21%ratherthanpriorstandardsof
100%,citinganarticleforwhich|amfirst-author:RichardsEM,FiskumG,RosenthalRE,
Hopkins |,McKenna MC. “Hyperoxic reperfusion afterglobalischemia decreases
hippocampalenergymetabolism”.Stroke.2007May;38(5):1578-84.Thisisincludedin
AdvancedCardiopulmonaryLifeSupport(ACLS)Trainingforfirst-responders.

EDUCATIONALACTIVITIES
Teaching
ClassroomInstruction
October2016 “ResearchEthics”Didactictrainingforpsychosomaticmedicinefellows.

ClinicalInstruction
NameofClerkship:MedstarGeorgetown/NIMHPsychosomaticMedicineFellowship
Role:AttendingPhysician,NIMHFellowshipAttending/ResearchMentor
CMEInstruction
April20,2020 GrandRounds:JohnsHopkinsHospital,Baltimore,MD
November10,2016. GrandRounds:UniversityofMassachusettsMedicalSchool,Worcester,MA.
Mentoring
1) NameofMentee: LauraNewman
DatesofMentorship:July2015-April2017.
Outcomes:Sharedpublications—1.
2) NameofMentee:GenevieveGilson
DatesofMentorship:May2016-August2016.
Outcomes:Accepted,TulaneSchoolofMedicineClassof2021.
3) Name ofMentee: Tessa Walls
Dates ofMentorship: July2013—July 2015
Outcome(s):
1) Sharedpublications-1
EricaM.Richards,MD,PhD CurriculumVitae Page9of11
2) CompletedLoyolaUniversityofMarylandMaster’sPlusPrograminPsychiatry,2016.
ORGANIZATIONALACTIVITIES
InstitutionalAdministrativeAppointments:
2020-presentDCHospitalAssociation:OpioidandSubstanceUseResponseWorkgroup
2017-presentDCHospitalAssoci BehavioralHealthCollaborativeGroupMember
2017-presentMember,MedicalExecutiveCommittee,SibleyMemorialHospital
2017-presentMember,PharmacyandTherapeuticsBoard,SibleyMemorialHospital
2017-present~Member,InfectionPreventionHospitalCommittee,SibleyMemorialHospital
2017-2019— Member,QualitySafetyandServiceCommittee,SibleyMemorialHospital
2017-2019 Mayor'sOpioidTaskForce,StrategicTeamLead,Washington,DC
2016-2017— Member,NIHIntramuralSeminarSeriesCommittee
2015-2016 BoardMember,NationalInstituteofMentalHealthFellowsCommittee
2014-2015 FounderandInstructor,ResearchAssistantClinicalTrainingWorkshop
2014-2015 NIMHRepresentative,NIHClinicalFellowsCommittee

ProfessionalSocieties
2015-2019 AmericanSocietyofClinicalPsychopharmacology
2009-2019 AmericanPsychiatricAssociation
1999-2008

RECOGNITION
InvitedTalks/Media:
WorldBreastfeedingWeek,SibleyHospital:Invitedspeaker,“PostpartumDepression”;August2019
\gton,DC)On-AirInterview:“Ketamine-ANewTreatmentforDepression”,April

WHUR 96.3(Washington,DC)TownKallPanelist:“TheOpioidCrisis”,March2019
Fox5MorningLocalNews(Washington,DC)On-AirInterview:“BipolarDisorder”,April2018
CBS“OffScriptwithBruceJohnson”On-AirInterview:BipolarDisorder,April2018
GrandRounds:“DepressionandInflammation:HowdoWe CalmtheFire?”.HowardUniversity.
Washington,DCMarch2018.

GrandRounds:“Biomarkers,BrainDiseaseandInflammation”.UniversityofMassachusettsMedical
‘School,Worcester,MA.November2016.
Symposiumspeaker:“PETimagingandNeuroinflammation”.AmericanCollegeof
Neuropsychopharmacology(ACNP)meeting.Hollywood,FL.December2015.
EricaM.Richards,MD,PhD CurriculumVitae Page10of11,
Keynotespeaker:“NewOptionsfortheTreatmentofDepression”.NationalAllianceonMentalIllness
(NAMI)AnnualConference,Huron,SD.October2015.
Keynotespeaker:“NavigatingYourPathTowardsaCareerinScience”.AllianceforGraduateEducation
andtheProfessoriate(AGEP)ResearchSymposium,CollegePark,MD. January2006.
Awards, Honors
TopPosterAward—ClinicalResearch,SocietyofBiologicalPsychiatry(SOBP),2016
TravelAward,AmericanCollegeofNeuropsychopharmacology(ACNP),2015
NewInvestigatorAward,AmericanSocietyforClinicalPsychopharmacology(ASCP),2015
YoungInvestigatorAward,CareerDevelopmentInstitute(CDI)forBipolarDisorder,2015
InvitedFellow,NIMHBrainCamp,2014
InternoftheYearAward,JohnsHopkinsBayviewDepartmentofPsychiatry,2009
FirstPlace,OralPresentation,UniversityofMarylandGraduateStudentResearchDay,2005
MD/PhDOutstandingScholarAward,UniversityofMaryland,Baltimore,1999
PhiBetaKappa,EpsilonofGeorgia,1999
GoldenKeyNationalHonorSociety,1999
MortarBoardSeniorHonorSociety,1998
NationalinstitutesofHealthUndergraduateScholarshipRecipient,1997,1998
Member,AlphaLambdaDeltaHonorSociety,1997
Captain,SpelmanCollegeSoccerTeam,1996-1998

OTHERPROFESSIONALACCOMPLISHMENTS
RichardsEM,Zanotti-FregonaraP,FujitaM,Walls,NiciuMJ,ParkM,Machado-VieiraR,SalvadoreG,
KolbH,ZarateCA,InnisRB.“IncreasedPETradioligandbindingtotranslocatorproteinsuggeststhat
majordepressivedisorderisassociatedwithneuroinflammation”.Posterpresentation,Societyof
BiologicalPsychiatry.Toronto,Canada.May2015.
RichardsEM,BallardED,NiciuMJ,VandeVoortJ,LuckenbaughDA,ZarateCA.“GenderDifferencesin
AntidepressantResponsetoKetamine”.PosterPresentation,SixthWorldCongressonWomen’sMental
Health.Tokyo,Japan.March2015.
RichardsEM,MathewsD,Machado-VieiraR,NiciuM,lonescuD,NolanN,Franco-ChavesJ,HudzikT,MaciagC,ShuangL,SmithM,LuckenbaughDA,Zarate,JrC.“ARandomized,Placebo-Controlled,Pilot
Trialofa DeltaOpioidAgonistinPatientswithAnxiousMajorDepression”.Posterpresentation,Society
ofBiologicalPsychiatry.NewYork,NY.May2014.

Martin€,VereczkiV,RosenthalR,andFiskumG.“TargetingofthePyruvateDehydrogenaseComplexby
Oxidative Stressduring Cerebral Ischemia/Reperfusion”. Abstract printed and poster presentated at
SocietyforNeuroscienceConference.SanDiego,CA.October2004.
MartinE,VereczkiV,RosenthalRandFiskumG.“ThePyruvateDehydrogenaseComplexasaTargetof
OxidativeStressDuringCerebralischemia/Reperfusion”.Invitedtalk,Mitochondriaand
NeuroprotectionSymposium.Ft.Lauderdale,FL.April2004.
EricaM.Richards,MD,PhD CurriculumVitae Page11of11
MartinE,RicePandHasdayJ.“TheInfluenceofFeveronSurvivalDuringanAntibiotic-Treated
PneumoniaInfection”.MedicalStudentResearchDay.Baltimore,MD. 2000

Executive Office of the Mayor – Mayor’s Office of Talent and Appointments
John A. Wilson Building | 1350 Pennsylvania Avenue, Suite 600 | Washington, DC 20004

Erica Richards, M.D., Ph.D.

Dr. Erica Richards is a board -certified adult psychiatrist. She is
currently the chair and medical director of the Department of Psychiatry
and Behavioral Health at Sibley Memorial Hospital, as well as an
assistant professor in the Department of Psychiatry and Behavioral
Sciences at the Johns Hopkins University School of Medicine. Dr.
Richards is board certified in psychiatry by the American Board of
Psychiatry and Neurology.
Dr. Richards is a member of the American Society of Clinical
Psychopharmacology and the American Psychiatric Association. She
previously served as the founder and instructor for the Research
Assistant Clinical Training Workshop, a National Institute of Mental Health representative for the
National Institutes of Health Clinical Fellows Committee , and a board member for the National
Institute of Mental Health Fellows Committee.
Dr. Richards has earned the Top Poster Award for Clinical Research by the Society of Biological
Psychiatry; a Travel Award by the American College of Neuropsychopharmacology, a Young
Investigator Award by the Career Development Institute for Bipolar Disorder, a New Investigator
Award for the American Society of Clinical Psychopharmacology, as well as several other
distinctions during her years of study.
Dr. Richards has contributed to numerous publications with her research interests on investigating
the role of inflammation in the pathophysiology of mood disorders, identifying potential
biomarkers of depression and treatment response, and elucidating the mechanism of action of
ketamine's antidepressant effects. The National Institutes of Health and the American Heart
Association have both provided funding for her research on the effects of heart attack and stroke
on the brain, specifically on mitochondrial function following ischemia. She has authored over 30
peer-reviewed research publications in the fields of neuroscience and psychiatry research.
A Ward 4 resident, Dr. Richards earned her Bachelor of Science in Biology from Spelman College
and both her PhD in Neuroscience and her Doctor of Medicine from University of Maryland.

GOVERNMENT OF THE DISTRICT OF COLUMBIA
Executive Office of Mayor Muriel Bowser

Office of the General Counsel to the Mayor

______________________________________________________________________________
The John A. Wilson Building • 1350 Pennsylvania Avenue, NW • Suite 300 • Washington, D.C. 20004 • Office (202) 724-7681

To: Kimberly A. Bassett, Steve Walker
From: Betsy Cavendish
Date: October 7, 2024
Subject: Legal sufficiency review of a resolution reappointing Dr. Erica Richards as a
member of the Violence Fatality Review Committee
This is to Certify that this office has reviewed the above-referenced Order and found
it to be legally unobjectionable. If you have any questions in this regard, please do not hesitate
to call Michael Porcello, Deputy General Counsel, Executive Office of the Mayor, at 202-727-
0872, or me at 202-724-7681.

______________________________
Elizabeth Cavendish